TCAG2M is partnered with the University of Arizona Genetics Core (UAGC) to support a clinical services division, offering high-quality molecular diagnostic tests backed by research. The Clinical Services Laboratory at the UAGC supports clinical, clinical trial, and clinical research activities, as well as the inpatient and outpatient needs of physicians and researchers.
The UAGC:CS offers testing for:
- Solid tumors, detecting single nucleotide variants (SNVs) and small insertions/deletions that are targets for cancer therapeutics or diagnosis
- Recurrence risk for breast cancer using the Prosignia assay
- Clinical exome sequencing
UAGC-CS is CLIA and CAP certified for high complexity laboratory testing involving NGS-based assays. This infrastructure includes a custom software suite allowing for the analysis of patient data and preparation of comprehensive reports to physicians. UAGC-CS has trained staff to meet all clinical standards (HIPPA, GLP, CLIA, CAP) for the processing, tracking, and analysis of clinical patient data. This includes novel bioinformatics pipelines designed to integrate UA high throughput computing for the discovery and/or identification of causative mutations.